Anaplastic multiple myeloma with MYC rearrangement

被引:0
|
作者
Ichikawa, Satoshi [1 ,5 ]
Fukuhara, Noriko [1 ]
Hashimoto, Ko [2 ]
Fujishima, Fumiyoshi [3 ]
Ichinohasama, Ryo [4 ]
Harigae, Hideo [1 ]
机构
[1] Tohoku Univ Hosp, Dept Hematol, Sendai, Japan
[2] Tohoku Univ Hosp, Dept Orthopaed Surg, Sendai, Japan
[3] Tohoku Univ Hosp, Dept Pathol, Sendai, Japan
[4] Tohoku Univ Hosp, Dept Hematopathol, Sendai, Japan
[5] Tohoku Univ Hosp, Dept Hematol, 1-1 Seiryo Cho, Sendai 9808574, Japan
来源
LEUKEMIA RESEARCH REPORTS | 2022年 / 17卷
关键词
Anaplastic multiple myeloma; MYC rearrangement; 1q21; aberration; Conventional chemotherapy;
D O I
10.1016/j.lrr.2021.100288
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 52-year-old man with rapidly progressive paraplegia was presented to us with paravertebral tumors. Lam-inectomy with tumor resection was performed, and pathological analysis of the tumor revealed compact pro-liferation of anaplastic plasmacytoid cells. G-band analysis of the tumor revealed a complex karyotype, including IgH/MYC translocation. The patient was diagnosed with anaplastic multiple myeloma (AMM) with MYC arrangement, and cytotoxic chemotherapy followed by autologous hematopoietic stem cell transplantation resulted in long-term disease-free remission. This is the first report describing a case of de novo AMM with MYC rearrangement, suggesting that conventional chemotherapy could be a treatment option for this formidable disease.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] When to test MYC rearrangement in multiple myeloma patients
    Kebe, Ana Doplihar
    Cibej, Hermina
    Nussdorfer, Judita
    Zver, Samo
    Podgornik, Helena
    [J]. MOLECULAR CYTOGENETICS, 2019, 12
  • [2] DIAGNOSIS AND PROGNOSIS OF MULTIPLE MYELOMA. IMPLICATION OF MYC REARRANGEMENT
    De La Torre, Corona Laura
    Morales, Camacho Rosario Maria
    Caballero, Velazquez Teresa
    Gonzalez, Carrasco Noelia
    Prats, Martin Concepcion
    Vargas, De Los Monteros Maria Teresa
    [J]. HAEMATOLOGICA, 2020, 105 : 166 - 167
  • [3] Myc rearrangement redefines the stratification of high-risk multiple myeloma
    Jin, Xianghong
    Li, Hui
    Zhang, Dingding
    Liu, Shuangjiao
    Song, Yuhang
    Zhang, Fujing
    Li, Ziping
    Zhuang, Junling
    [J]. CANCER MEDICINE, 2024, 13 (11):
  • [4] Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement
    Khanlari, Mahsa
    Tang, Guilin
    Hao, Suyang
    Gong, Yun
    Li, Shaoying
    Miranda, Roberto N.
    Lin, Pei
    Iyer, Swaminathan
    Yin, Cameron C.
    Xie, Wei
    Vega, Francisco
    Medeiros, L. J.
    Xu, Jie
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : E17 - E21
  • [5] Anaplastic Multiple Myeloma with Multiple Genetic Anomalies
    Demircioglu, Sinan
    Tekinalp, Atakan
    Ceneli, Ozcan
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (01): : 132 - 133
  • [6] MYC inhibitors in multiple myeloma
    Martinez-Martin, Sandra
    Soucek, Laura
    [J]. CANCER DRUG RESISTANCE, 2021, 4 (04) : 842 - 865
  • [7] Targeting MYC in multiple myeloma
    Jovanovic, K. K.
    Roche-Lestienne, C.
    Ghobrial, I. M.
    Facon, T.
    Quesnel, B.
    Manier, S.
    [J]. LEUKEMIA, 2018, 32 (06) : 1295 - 1306
  • [8] Relapsed Multiple Myeloma with Anaplastic Transformation
    Durgadevi Sundaresan
    Snehvarsha Bhagat
    Sreejesh Sreedharanunni
    Man Updesh Singh Sachdeva
    Pankaj Malhotra
    Praveen Sharma
    [J]. Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 179 - 180
  • [9] ANAPLASTIC TRANSFORMATION OF MULTIPLE-MYELOMA
    LEE, SL
    [J]. CANCER INVESTIGATION, 1990, 8 (05) : 569 - 569
  • [10] Anaplastic morphology in IgD multiple myeloma
    Galiacho, Veronica Roldan
    Gamiz, Maite Moreno
    Arteaga, Idoya Ancin
    Varela, Marta Alonso
    Diez, Elena Amutio
    Garcia-Ruiz, Juan Carlos
    [J]. HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (04) : 521 - 523